By Fineline Cube 
China-based Meinian Onehealth Healthcare (Group) Co., Ltd (SHE: 002044) has entered into a partnership with The Academy for Discovery, Adventure, Momentum and Outlook (Alibaba DAMO Academy). The collaboration aims to leverage DAMO Academy’s proprietary “One Scan, Multiple Detections” medical AI technology to jointly advance screening for critical diseases such as cancer and chronic conditions, while also exploring innovations in intelligent health checkup services.
DAMO Academy’s AI Technology
DAMO Academy, Alibaba Group’s premier research and talent hub, pioneered the groundbreaking “One Scan, Multiple Detections” AI technology. This innovation utilizes a single non-contrast CT scan to identify multiple subtle lesions that are undetectable by the human eye. The technology has been deployed for pancreatic cancer, esophageal cancer, gastric cancer, colorectal cancer, liver cancer, and other cancers, as well as chronic diseases like osteoporosis, fatty liver, and emergencies such as aortic syndrome.
Collaboration Goals
Through this partnership, Meinian Onehealth and DAMO Academy will work together to enhance the efficiency and accuracy of disease screening. The collaboration will also focus on developing intelligent health checkup services, leveraging the power of AI to improve early detection and treatment of critical diseases.-Fineline Info & Tech